Guggenheim Capital’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Guggenheim Capital’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-21,895	Closed	-$402K	–	2197
2020 Q4	$402K	Hold	21,895	–	–	﹤0.01%	1723
2020 Q3	$402K	Buy	+21,895	New	+$368K	﹤0.01%	1522

Guggenheim Capital's CBMG Position: Q1 2021 in Review

Guggenheim Capital sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 21,895 shares — an estimated $402K sold.

Guggenheim Capital first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $402K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Guggenheim Capital reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Guggenheim Capital sold 21,895 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $402K.
Guggenheim Capital first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
Guggenheim Capital's Cellular Biomedicine Group, Inc. position peaked at $402K in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Guggenheim Capital's 13F filing for Q1 2021, filed 13 May 2021.